Fresenius Invests in BioIntellisense AI Platform
“We made this strategic investment in BioIntelliSense to enable our medical staff to more efficiently and effectively continuously monitor patients, facilitating precise and timely interventions and reducing cost to the system,” explains FMCNA CEO, Bill Valle.
Read the full article » | Posted 09-12-2019
- Fresenius CEO Rice Powell on Lessons Learned From Covid 19 Posted 05-12-2020
- Dialysis Industry Leaders Come Together to Fight Public Health Crisis Posted 04-13-2020
- Fresenius Telehealth Hub Posted 03-16-2020
- DaVita Care Connect Mobile App Posted 03-16-2020